Investment Opportunities
CleanSpace Technology
Fri 23rd October, 2020

Wilsons was pleased to act as Joint Lead Manager to CleanSpace Holdings Limited $131.4 million Initial Public Offering (IPO). Shares in the company were issued at $4.41 per share and the first day of trading saw shares close up 68% at $7.42 per share. The IPO positions the business to capitalise on its leading technology and market opportunity, and is the next step in providing financial flexibility and enabling the company to execute on its growth strategy.

Head of Corporate Finance Rob Snow said, “Wilsons are pleased to have been able to support another great business with its listing on the ASX. CleanSpace demonstrates that there is strong investor interest in innovative healthcare technology opportunities.”

Founded in Australia in 2009 by a team of biomedical engineers, CleanSpace manufactures respiratory protection equipment for workers in the healthcare and industrial sectors. Throughout the COVID-19 pandemic, CleanSpace reported a fourfold increase in demand for its respirators, and the company continues to grow with international approvals and established domestic and offshore teams supporting sales of a product portfolio to large healthcare and industrial RPE markets. 80% of masks produced by CleanSpace go overseas. Chief executive Alex Birrell said, the battery-powered masks are 10 times more effective at filtering particles than standard N95 masks used in many hospitals.

CleanSpace’s success is due in large part to their innovative technology which incorporates miniaturisation (size and weight), smart pressure driven algorithms, intuitive function and unique neck mounted design, to achieve the highest level of protection. In the last 10 years they have continued to invest in research and development programs resulting in differentiated design and approved products that provide compelling employer and user benefits, namely higher protection with improved compliance and productivity.

Wilsons is looking forward to assisting CleanSpace in the next phase of its journey as a listed company.

For more information contact:

Head of Corporate Finance, Rob Snow / (02) 8247 6645

Head of Corporate Finance Origination, Richard Sherman / (03) 9640 3879

About Wilsons: Wilsons is a financial advisory firm focused on delivering strategic and investment advice for people with ambition – whether they be a private investor, corporate, fund manager or global institution. Its client-first, whole of firm approach allows Wilsons to partner with clients for the long-term and provide the wide range of financial and advisory services they may require throughout their financial future. Wilsons is staff-owned and has offices across Australia.

Disclaimer: This communication has been prepared by Wilsons Advisory and Stockbroking Limited (ACN 010 529 665: AFSL 238 375) and Wilsons Corporate Finance Limited (ACN 057 547 323: AFSL 238 383) (“Wilsons”), and to the extent that it contains advice, that advice is general in nature and does not consider your personal circumstances.

The information in this communication does not take into consideration the investment objectives, financial situation or particular needs of any particular investor. Past performance is not a reliable indicator of future performance. On that basis, any advice should not be relied on to make any investment decisions without first consulting with your financial adviser. If you do not currently have an adviser, please contact us and we would be happy to connect you with a Wilsons representative.

To the extent that any specific documents or products are referred to, please also ensure that you obtain the relevant document or Product Disclosure Statement(s) before considering any related investments.

Wilsons and their associates may have received and may continue to receive fees from any company or companies referred to in this communication (the “Companies”) in relation to corporate advisory, underwriting or other professional investment services. Please see relevant Wilsons disclosures at

  • Share This Article

Written by

Staff Writer

Related articles